|
Research Management and Support
|
RMS2010 [E]
|
$345,370,533
|
N/A
|
National Cancer Institute
|
|
Children's Oncology Group Chair's Grant
|
5U10CA098543-08
|
$26,966,030
|
ADAMSON, PETER
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Mechanisms of T cell leukemia induction and maintenance
|
1R01CA149655-01
|
$350,675
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Modifiers of Notch stability and their role in cancer
|
1R21CA141399-01A2
|
$220,545
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Inherited bone marrow failure syndromes study
|
ZIA CP010144 07130
|
$1,589,054
|
Alter, Blanche
|
DCEG (NCI)
|
|
Children's Oncology Group Statistics and Data Center Grant
|
3U10CA098413-08S1
|
$1,499,003
|
ANDERSON, JAMES
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Children's Oncology Group Statistics and Data Center Grant
|
3U10CA098413-08S2
|
$39,636
|
ANDERSON, JAMES
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Children's Oncology Group Statistics and Data Center Grant
|
3U10CA098413-08S3
|
$39,636
|
ANDERSON, JAMES
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Children's Oncology Group Statistics and Data Center Grant
|
5U10CA098413-08
|
$5,935,261
|
ANDERSON, JAMES
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Collaborative Pathways that Lead to Leukemia
|
ZIA BC 010982
|
$289,223
|
Aplan, Peter
|
CCR (NCI)
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
ZIA SC 010378
|
$289,223
|
Aplan, Peter
|
CCR (NCI)
|
|
Mechanisms of Chromosomal Translocation
|
ZIA SC 010379
|
$289,223
|
Aplan, Peter
|
CCR (NCI)
|
|
Genetic Predictors of AML Treatment Response
|
1R01CA133881-01A2
|
$674,105
|
Aplenc, Richard
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
Molecular pathogenesis of MLL-AF4 leukemias
|
1R01CA140575-01A1
|
$355,690
|
ARMSTRONG, SCOTT
|
CHILDREN'S HOSPITAL BOSTON
|
|
Long-term Treatment Related CNS Injury in Survivors of Childhood Cancer
|
1R21CA138988-01A2
|
$230,133
|
Armstrong, Gregory
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Significance of Marrow Karyotypes in Inherited Bone Marrow Failure Syndromes
|
ZIA BC 010692
|
$71,905
|
Arthur, Diane
|
CCR (NCI)
|
|
Clinical Cancer Cytogenetics
|
ZID BC 010694
|
$503,334
|
Arthur, Diane
|
CCR (NCI)
|
|
Southeast Cancer Control Consortium, Inc
|
2U10CA045808-24
|
$2,264,660
|
ATKINS, JAMES
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
Tyrosine kinase inhibitors for the treatment of childhood AML
|
1R01CA138744-01A1
|
$348,600
|
BAKER, SHARYN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Metabolic Syndrome Following Transplant for Leukemia
|
5R01CA112530-05
|
$486,075
|
BAKER, KEVIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
WUMC Cancer and Leukemia Group B
|
5U10CA077440-13
|
$360,039
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S1
|
$124,531
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S2
|
$100,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S3
|
$100,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S4
|
$46,458
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-46
|
$11,641,774
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA022453-28S2
|
$2,443,826
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
Cancer Center Support Grant - Team Leadership Award
|
3P30CA022453-28S3
|
$50,000
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
Cancer Center Support Grant - Clinical Trials Reporting Supplement (CTRP)
|
3P30CA022453-28S4
|
$99,998
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
Pediaric Oncology Research Training Program
|
5T32CA009351-32
|
$218,479
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer and Leukemia Group B CCOP Research Base
|
2U10CA037447-26
|
$2,316,114
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B
|
3U10CA031946-29S3
|
$8,129,333
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B
|
7U10CA031946-29
|
$11,034,745
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Relapse after Allogeneci Hematopoietic Stem Cell Transplantation
|
ZIA BC 011239
|
$183,397
|
Bishop, Michael
|
CCR (NCI)
|
|
Cancer and Leukemia Group B - The Ohio State University
|
7U10CA077658-13
|
$503,136
|
BLOOMFIELD, CLARA
|
OHIO STATE UNIVERSITY
|
|
Minimal Residual Disease in Pediatric ALL in Relation to Other Prognostic Factors
|
5R01CA086011-10
|
$262,609
|
BOROWITZ, MICHAEL
|
JOHNS HOPKINS UNIVERSITY
|
|
Developing FLT3-Targeted Therapy for Pediatric Leukemia
|
5K23CA111728-05
|
$140,130
|
BROWN, PATRICK
|
JOHNS HOPKINS UNIVERSITY
|
|
Investigating the role of retrotransposons in hematopoietic neoplasias.
|
5K08CA134746-03
|
$140,130
|
BURNS, KATHLEEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Cancer and Leukemia Group B
|
5U10CA032291-29
|
$511,085
|
Burstein, Harold
|
DANA-FARBER CANCER INSTITUTE
|
|
GRAND RAPIDS CLINICAL ONCOLOGY PROGRAM
|
2U10CA035178-27
|
$1,358,665
|
BURY, MARTIN
|
SPECTRUM HEALTH HOSPITALS
|
|
Cancer Center Support Grant
|
3P30CA046934-23S1
|
$99,997
|
Byers, Tim
|
UNIVERSITY OF COLORADO DENVER
|
|
Cancer Center Support Grant
|
3P30CA046934-23S2
|
$99,946
|
Byers, Tim
|
UNIVERSITY OF COLORADO DENVER
|
|
The Ohio State University Comprehensive Cancer Center
|
3P30CA016058-34S4
|
$3,823,791
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
The Ohio State University Comprehensive Cancer Center
|
3P30CA016058-34S5
|
$100,000
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
The Ohio State University Comprehensive Cancer Center
|
3P30CA016058-34S6
|
$50,000
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
The Ohio State University Comprehensive Cancer Center
|
3P30CA016058-34S7
|
$80,000
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
The Ohio State University Comprehensive Cancer Center
|
3P30CA016058-34S8
|
$200,000
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer and Leukemia Group B - Leukemia Correlative Sciences
|
7U10CA101140-08
|
$829,642
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cell Therapy of Refractory Leukemia
|
5R01CA113482-05
|
$289,553
|
CAMPANA, DARIO
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Clinical Significance of Residual Myeloid Leukemia
|
5R01CA115422-05
|
$260,597
|
CAMPANA, DARIO
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|